SICAGEN INDIA Latest Share Price (SICAGEN)
TODAY IN ONE LINE
SICAGEN rose 1.1%, outperforming Nifty's -1.1% move.
With a market cap of ₹198.14 Cr., it trades at a P/E of 11.41. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
SICAGEN INDIA flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Reasonable ValuationTrading at a moderate P/E of 12.6x
- ●Steady Dividend YieldReliable 1.98% dividend yield
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.13x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 3.1%
Latest SICAGEN INDIA News
What changed recently?
Recent events, corporate actions, and announcements.
SICAGEN INDIA valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for SICAGEN INDIA, framed against the sector median so the premium or discount is obvious at a glance.
SICAGEN INDIA trades at a P/E of 11.41× and P/B of 0.47×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
SICAGEN INDIA technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for SICAGEN INDIA — derived from the latest tape, not yesterday's close.
SICAGEN INDIA last traded at ₹51.48 with an intraday range of ₹50.25–₹51.89 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹51.48| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 55.44 | +3.96 | +7.70% |
| R3 | 53.80 | +2.32 | +4.51% |
| R2 | 52.85 | +1.37 | +2.65% |
| R1 | 52.16 | +0.68 | +1.33% |
| PIVOT | 51.21 | -0.27 | -0.53% |
| CURRENT | 51.48 | — | — |
| S1 | 50.52 | -0.96 | -1.86% |
| S2 | 49.57 | -1.91 | -3.72% |
| S3 | 48.88 | -2.60 | -5.04% |
| S4 | 47.24 | -4.24 | -8.23% |
SICAGEN is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹50.25–₹50.25
Trading Inside opening range
SICAGEN INDIA financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for SICAGEN INDIA — consolidated or standalone — with margins, YoY growth and key ratios inline.
SICAGEN INDIA reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹198.14 Cr. and reported EPS of ₹1.75.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 973 | 973 ▲ 0.0% |
| Sales Growth YoY %Derived | 9.15% | 9.15% |
| Other Income | 10 | 10 ▲ 0.0% |
| Total Income | 983 | 983 ▲ 0.0% |
| 861 | 861 ▲ 0.0% | |
| Gross ProfitDerived | 113 | 113 ▲ 0.0% |
| Gross Margin %Derived | 11.59% | 11.59% |
| 74 | 74 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 39 | 39 ▲ 0.0% |
| OPM %Derived | 4.04% | 4.04% |
| 23 | 23 ▲ 0.0% | |
| Profit Before Tax (PBT) | 25 | 25 ▲ 0.0% |
| 7 | 7 ▲ 0.0% | |
| Effective Tax %Derived | 28.44% | 28.44% |
| Total Profit for Period | 18 | 18 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 18 | 18 ▲ 0.0% |
| Net Profit Margin %Derived | 1.86% | 1.86% |
| PAT Growth YoY %Derived | 5.61% | 5.61% |
| Earnings Per Share (EPS ₹) | 4.57 | 4.57 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -23 | -23 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 958 | 958 ▲ 0.0% |
| Material Cost % of RevenueDerived | 47.13% | 47.13% |
| Employee Cost % of RevenueDerived | 3.18% | 3.18% |
| Other Cost % of RevenueDerived | 4.37% | 4.37% |
| Interest Coverage (x)Derived | 2.24x | 2.24x |
| Period | Mar 2018 | May 2018 | Mar 2019 | May 2019 | Mar 2020 | Jun 2020 | Mar 2021 | May 2021 | Mar 2022 | Jun 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | May 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 740 | 740 ▲ 0.0% | 820 ▲ 10.9% | 820 ▲ 0.0% | 699 ▼ 14.8% | 699 ▲ 0.0% | 542 ▼ 22.5% | 542 ▲ 0.0% | 836 ▲ 54.4% | 836 ▲ 0.0% | 895 ▲ 7.1% | 895 ▲ 0.0% | 795 ▼ 11.2% | 795 ▲ 0.0% | 892 ▲ 12.1% | 892 ▲ 0.0% | 973 ▲ 9.1% | 973 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | 10.87% | 10.87% | -14.81% | — | -22.50% | — | 54.37% | — | 7.08% | — | -11.15% | -11.15% | 12.12% | 12.12% | 9.15% | 9.15% | |
| Other Income | 15 | 15 ▲ 0.0% | 17 ▲ 13.9% | 17 ▲ 0.0% | 11 ▼ 34.2% | 11 ▲ 0.0% | 8 ▼ 24.2% | 8 ▲ 0.0% | 9 ▲ 2.7% | 9 ▲ 0.0% | 8 ▼ 4.8% | 8 ▲ 0.0% | 7 ▼ 13.3% | 7 ▲ 0.0% | 8 ▲ 13.5% | 8 ▲ 0.0% | 10 ▲ 21.3% | 10 ▲ 0.0% | |
| Total Income | 755 | 755 ▲ 0.0% | 837 ▲ 10.9% | 837 ▲ 0.0% | 710 ▼ 15.2% | 710 ▲ 0.0% | 550 ▼ 22.5% | 550 ▲ 0.0% | 845 ▲ 53.6% | 845 ▲ 0.0% | 903 ▲ 7.0% | 903 ▲ 0.0% | 803 ▼ 11.2% | 803 ▲ 0.0% | 900 ▲ 12.1% | 900 ▲ 0.0% | 983 ▲ 9.3% | 983 ▲ 0.0% | |
652 | 652 ▲ 0.0% | 731 ▲ 12.1% | 731 ▲ 0.0% | 620 ▼ 15.1% | 620 ▲ 0.0% | 477 ▼ 23.1% | 477 ▲ 0.0% | 761 ▲ 59.6% | 761 ▲ 0.0% | 810 ▲ 6.3% | 810 ▲ 0.0% | 711 ▼ 12.2% | 711 ▲ 0.0% | 790 ▲ 11.1% | 790 ▲ 0.0% | 861 ▲ 9.0% | 861 ▲ 0.0% | ||
| Gross ProfitDerived | 88 | 88 ▲ 0.0% | 90 ▲ 1.8% | 90 ▲ 0.0% | 79 ▼ 12.3% | 79 ▲ 0.0% | 65 ▼ 17.9% | 65 ▲ 0.0% | 75 ▲ 15.6% | 75 ▲ 0.0% | 86 ▲ 14.8% | 86 ▲ 0.0% | 85 ▼ 1.2% | 85 ▲ 0.0% | 102 ▲ 20.6% | 102 ▲ 0.0% | 113 ▲ 10.5% | 113 ▲ 0.0% | |
| Gross Margin %Derived | 11.91% | 11.91% | 10.93% | 10.93% | 11.26% | 11.26% | 11.93% | 11.93% | 8.93% | 8.93% | 9.58% | 9.58% | 10.64% | 10.64% | 11.45% | 11.45% | 11.59% | 11.59% | |
87 | 87 ▲ 0.0% | 88 ▲ 1.3% | 88 ▲ 0.0% | 67 ▼ 23.7% | 67 ▲ 0.0% | 56 ▼ 16.7% | 56 ▲ 0.0% | 53 ▼ 6.1% | 53 ▲ 0.0% | 59 ▲ 12.3% | 59 ▲ 0.0% | 58 ▼ 2.9% | 58 ▲ 0.0% | 67 ▲ 15.8% | 67 ▲ 0.0% | 74 ▲ 10.4% | 74 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 1 | 1 ▲ 0.0% | 1 ▲ 41.2% | 1 ▲ 0.0% | 11 ▲ 686.1% | 11 ▲ 0.0% | 8 ▼ 25.2% | 8 ▲ 0.0% | 22 ▲ 159.1% | 22 ▲ 0.0% | 27 ▲ 20.8% | 27 ▲ 0.0% | 27 ▲ 2.5% | 27 ▲ 0.0% | 36 ▲ 30.7% | 36 ▲ 0.0% | 39 ▲ 10.7% | 39 ▲ 0.0% | |
| OPM %Derived | 0.14% | 0.14% | 0.18% | 0.18% | 1.62% | 1.62% | 1.56% | 1.56% | 2.63% | 2.63% | 2.96% | 2.96% | 3.41% | 3.41% | 3.98% | 3.98% | 4.04% | 4.04% | |
14 | 14 ▲ 0.0% | 15 ▲ 9.1% | 15 ▲ 0.0% | 19 ▲ 23.3% | 19 ▲ 0.0% | 15 ▼ 18.7% | 15 ▲ 0.0% | 8 ▼ 47.3% | 8 ▲ 0.0% | 26 ▲ 217.5% | 26 ▲ 0.0% | 20 ▼ 20.8% | 20 ▲ 0.0% | 24 ▲ 15.9% | 24 ▲ 0.0% | 23 ▼ 1.9% | 23 ▲ 0.0% | ||
| Profit Before Tax (PBT) | 2 | 2 ▲ 0.0% | 3 ▲ 72.1% | 3 ▲ 0.0% | 3 ▲ 20.1% | 3 ▲ 0.0% | 1 ▼ 57.8% | 1 ▲ 0.0% | 5 ▲ 247.9% | 5 ▲ 0.0% | 22 ▲ 331.9% | 22 ▲ 0.0% | 14 ▼ 36.0% | 14 ▲ 0.0% | 24 ▲ 74.7% | 24 ▲ 0.0% | 25 ▲ 4.4% | 25 ▲ 0.0% | |
1 | 1 ▲ 0.0% | 3 ▲ 442.0% | 3 ▲ 0.0% | 3 ▲ 12.5% | 3 ▲ 0.0% | 5 ▲ 52.1% | 5 ▲ 0.0% | 6 ▲ 21.1% | 6 ▲ 0.0% | 4 ▼ 32.0% | 4 ▲ 0.0% | 3 ▼ 12.3% | 3 ▲ 0.0% | 7 ▲ 111.0% | 7 ▲ 0.0% | 7 ▲ 1.6% | 7 ▲ 0.0% | ||
| Effective Tax %Derived | 30.30% | 30.30% | 95.42% | 95.42% | 89.44% | 89.44% | 322.22% | 322.22% | 112.18% | 112.18% | 17.65% | 17.65% | 24.21% | 24.21% | 29.24% | 29.24% | 28.44% | 28.44% | |
| Total Profit for Period | 1 | 1 ▲ 0.0% | 0 ▼ 88.7% | 0 ▲ 0.0% | 0 ▲ 176.9% | 0 ▲ 0.0% | -3 ▼ 988.9% | -3 ▲ 0.0% | -1 ▲ 80.9% | -1 ▲ 0.0% | 18 ▲ 3021.3% | 18 ▲ 0.0% | 10 ▼ 41.1% | 10 ▲ 0.0% | 17 ▲ 63.1% | 17 ▲ 0.0% | 18 ▲ 5.6% | 18 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 1 | 1 ▲ 0.0% | 0 ▼ 88.7% | 0 ▲ 0.0% | 0 ▲ 176.9% | 0 ▲ 0.0% | -3 ▼ 988.9% | -3 ▲ 0.0% | -1 ▲ 80.9% | -1 ▲ 0.0% | 18 ▲ 3021.3% | 18 ▲ 0.0% | 10 ▼ 41.1% | 10 ▲ 0.0% | 17 ▲ 63.1% | 17 ▲ 0.0% | 18 ▲ 5.6% | 18 ▲ 0.0% | |
| Net Profit Margin %Derived | 0.16% | 0.16% | 0.02% | 0.02% | 0.05% | 0.05% | -0.59% | -0.59% | -0.07% | -0.07% | 1.99% | 1.99% | 1.32% | 1.32% | 1.92% | 1.92% | 1.86% | 1.86% | |
| PAT Growth YoY %Derived | — | — | -88.70% | -88.70% | 176.92% | — | -988.89% | — | 80.94% | — | 3,021.31% | — | -41.13% | -41.13% | 63.11% | 63.11% | 5.61% | 5.61% | |
| Earnings Per Share (EPS ₹) | 0.29 | 0.29 ▲ 0.0% | 0.03 ▼ 89.7% | 0.03 ▲ 0.0% | 0.09 ▲ 200.0% | 0.09 ▲ 0.0% | -0.81 ▼ 1000.0% | -0.81 ▲ 0.0% | -0.15 ▲ 81.5% | -0.15 ▲ 0.0% | 4.50 ▲ 3100.0% | 4.50 ▲ 0.0% | 2.65 ▼ 41.1% | 2.65 ▲ 0.0% | 4.32 ▲ 63.0% | 4.32 ▲ 0.0% | 4.57 ▲ 5.8% | 4.57 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 1 | 1 ▲ 0.0% | -8 ▼ 714.4% | -8 ▲ 0.0% | -8 ▲ 3.7% | -8 ▲ 0.0% | 16 ▲ 304.7% | 16 ▲ 0.0% | 27 ▲ 70.4% | 27 ▲ 0.0% | -11 ▼ 141.2% | -11 ▲ 0.0% | 12 ▲ 206.7% | 12 ▲ 0.0% | 6 ▼ 51.3% | 6 ▲ 0.0% | -23 ▼ 487.3% | -23 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 753 | 753 ▲ 0.0% | 834 ▲ 10.8% | 834 ▲ 0.0% | 706 ▼ 15.3% | 706 ▲ 0.0% | 549 ▼ 22.4% | 549 ▲ 0.0% | 840 ▲ 53.1% | 840 ▲ 0.0% | 882 ▲ 5.0% | 882 ▲ 0.0% | 789 ▼ 10.6% | 789 ▲ 0.0% | 876 ▲ 11.0% | 876 ▲ 0.0% | 958 ▲ 9.4% | 958 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 24.93% | 24.93% | 23.35% | 23.35% | 42.20% | 42.20% | 35.49% | 35.49% | 50.06% | 50.06% | 52.34% | 52.34% | 39.59% | 39.59% | 38.51% | 38.51% | 47.13% | 47.13% | |
| Employee Cost % of RevenueDerived | 5.29% | 5.29% | 5.56% | 5.56% | 5.04% | 5.04% | 5.81% | 5.81% | 2.82% | 2.82% | 2.66% | 2.66% | 3.10% | 3.10% | 3.22% | 3.22% | 3.18% | 3.18% | |
| Other Cost % of RevenueDerived | 6.48% | 6.48% | 5.20% | 5.20% | 4.60% | 4.60% | 4.56% | 4.56% | 3.48% | 3.48% | 3.96% | 3.96% | 4.13% | 4.13% | 4.25% | 4.25% | 4.37% | 4.37% | |
| Interest Coverage (x)Derived | -0.45x | -0.45x | -0.53x | -0.53x | 0.13x | 0.13x | -0.27x | -0.27x | 1.87x | 1.87x | 1.80x | 1.80x | 1.63x | 1.63x | 2.27x | 2.27x | 2.24x | 2.24x |
SICAGEN INDIA segment analysis : revenue and profit mix.
Disclosed business segments at SICAGEN INDIA with their share of revenue and profit, switchable between consolidated and standalone reporting.
SICAGEN INDIA discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for SICAGEN INDIA.
Our AI distills the core fundamental drivers supporting SICAGEN INDIA, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
What you're getting.
No strengths or opportunities on record.
Key Risks.
No weaknesses or threats on record.
Flip Conditions.
Valuation risk. a P/E above 15 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
SICAGEN INDIA peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — SICAGEN INDIA is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
SICAGEN INDIA chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for SICAGEN INDIA — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
SICAGEN INDIA delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for SICAGEN INDIA over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in SICAGEN INDIA stood at 62.0% of traded volume, against a 20-day average of 78.9%.
SICAGEN INDIA announcements: results, concalls, ratings, M&A.
Filings SICAGEN INDIA sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
SICAGEN INDIA files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 39 documents below.
Insider Trading / SAST
Intimation of Trading Window Closure for the Quarter & Half year ended 30th September, 2026.
Company Update
Letters dispatch to shareholders under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015 is attached herewith.
Company Update
Notice of 22nd Annual General Meeting along with the e-voting instructions and book closure details published in Newspapers i.e. Business Standard…
SICAGEN INDIA dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue SICAGEN INDIA has declared, sequenced by announce and record date.
SICAGEN INDIA corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About SICAGEN INDIA: business, sector, key facts.
What SICAGEN INDIA does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
SICAGEN INDIA is a listed Indian equity, listed as NSE: SICAGEN, BSE: 533014.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- AARVI ENCON (AARVI) Share PricePeer
- ABMINTLLTD (ABMINTLLTD) Share PricePeer
- ACCURACY SHIPPING (ACCURACY) Share PricePeer
- ACE INTEGRATED SOLU (ACEINTEG) Share PricePeer
- ACLGATI (ACLGATI) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about SICAGEN INDIA (SICAGEN).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of SICAGEN INDIA (SICAGEN)?
The current share price of SICAGEN INDIA (SICAGEN) is ₹51.48. Today, the stock has gained by ₹0.57 (1.12%), trading in a range of ₹50.25 to ₹51.89. The stock opened at ₹50.25 with a trading volume of 382 shares.
02Is SICAGEN INDIA stock a good investment for long-term?
SICAGEN INDIA can be considered for long-term investment based on several factors. The company has a market capitalization of ₹198.14 Cr., P/E ratio of 11.41, ROE of 3.07%, and ROCE of 4.15%. The dividend yield stands at 1.98%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of SICAGEN INDIA stock?
The 52-week high price of SICAGEN INDIA (SICAGEN) is ₹74.06, while the 52-week low is ₹46.55. Currently trading at ₹51.48, the stock is 10.59% above its 52-week low and 30.49% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy SICAGEN INDIA stock at the current price?
Whether to buy SICAGEN INDIA stock at ₹51.48 depends on multiple factors. The stock is currently trading with a P/E ratio of 11.41 and P/B ratio of 0.47. Today's performance shows a gain of 1.12%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of SICAGEN INDIA and when is the next dividend?
SICAGEN INDIA offers a dividend yield of 1.98%, which means for every ₹100 invested at the current price of ₹51.48, you can expect to receive approximately ₹1.98 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of SICAGEN INDIA?
SICAGEN INDIA's key financial metrics include: P/E Ratio: 11.41, P/B Ratio: 0.47, ROE: 3.07%, ROCE: 4.15%, Dividend Yield: 1.98%, EPS: ₹1.75, Book Value: ₹125.09, and Debt-to-Equity: 0.13. The company's market cap stands at ₹198.14 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is SICAGEN INDIA stock performing today in the market?
SICAGEN INDIA stock opened at ₹50.25 and is currently trading at ₹51.48, showing a gain of ₹0.57 (1.12%). The intraday high is ₹51.89 and low is ₹50.25. The trading volume stands at 382 shares, indicating moderate market participation today.
08What is the P/E ratio of SICAGEN INDIA and what does it indicate?
SICAGEN INDIA has a Price-to-Earnings (P/E) ratio of 11.41, which means investors are willing to pay 11.41 for every ₹1 of earnings. With an EPS of ₹1.75, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about SICAGEN INDIA (SICAGEN) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.